| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |